COLORADO DENVER UNIVERSITY OF

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Evaluating Color Perception Under LED Red/Green and Green Dominant Light

Completed

Conditions: Color Blindness, Acquired

Interventions: Device: White LED Flashlight
Device: Red/Green Green Dominant LED Flashlight

First Posted Date: 2013-08-22

Last Posted Date: 2019-05-15

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 39

Registration Number: NCT01927536

Locations: 🇺🇸
University of Colorado Dept of Opthalmology, Aurora, Colorado, United States

Platelet Rich Plasma vs Hyaluronic-Acid in Hip OA (Osteoarthritis)

Not Applicable

Completed

Conditions: Hip Osteoarthritis

Interventions: Device: Hyaluronic Acid
Biological: PRP

First Posted Date: 2013-08-09

Last Posted Date: 2021-03-03

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 38

Registration Number: NCT01920152

Locations: 🇺🇸
University of Colorado, Hip Preservation Center, Orthopedic Department, Boulder, Colorado, United States

Iloperidone for Symptoms of Arousal in Post Traumatic Stress Disorder (PTSD)

Phase 2

Terminated

Conditions: Post Traumatic Stress Disorder

Interventions: Drug: Iloperidone
Drug: Placebo

First Posted Date: 2013-08-06

Last Posted Date: 2020-02-11

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 1

Registration Number: NCT01917318

Locations: 🇺🇸
University of Colorado Depression Center; Clinical and Translational Research Center (CTRC), Aurora, Colorado, United States

Effectiveness of Continuous Femoral Nerve Block Versus Single Shot Femoral Nerve Block for Pain Control

Not Applicable

Terminated

Conditions: Post-operative Pain

Interventions: Drug: Bupivicaine
Drug: placebo

First Posted Date: 2013-08-05

Last Posted Date: 2016-08-01

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 7

Registration Number: NCT01916590

Locations: 🇺🇸
University of Colorado Hospital, Aurora, Colorado, United States

Autologous CD117+ Progenitor Cell Mobilization for Lung Transplantation

Phase 1

Completed

Conditions: COPD
Cystic Fibrosis
Pulmonary Fibrosis

Interventions: Drug: Plerixafor mobilization of autologous CD117 stem cells

First Posted Date: 2013-08-05

Last Posted Date: 2018-02-08

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 15

Registration Number: NCT01916577

Locations: 🇺🇸
University of Colorado Hospital, Aurora, Colorado, United States

Trebananib (AMG 386) in Combination With Docetaxel for Advanced Urothelial Carcinoma

Phase 2

Withdrawn

Conditions: Urothelial Carcinoma

Interventions: Drug: AMG 386
Drug: Docetaxel

First Posted Date: 2013-07-24

Last Posted Date: 2014-04-29

Lead Sponsor: University of Colorado, Denver

Registration Number: NCT01907308

Phosphatidylcholine Supplementation in Infants

Phase 1

Withdrawn

Conditions: Schizophrenia
Diminished P50 Sensory Gating

Interventions: Drug: phosphatidylcholine supplementation
Drug: placebo

First Posted Date: 2013-07-23

Last Posted Date: 2020-09-02

Lead Sponsor: University of Colorado, Denver

Registration Number: NCT01905605

Locations: 🇺🇸
University of Colorado Denver, Aurora, Colorado, United States

Effects of Dietary Omega-3 Fatty Acids on Reproductive Hormones in Obese Women

Not Applicable

Completed

Conditions: Fertility
Obesity

Interventions: Dietary Supplement: LOVAZA
Drug: GnRH

First Posted Date: 2013-07-10

Last Posted Date: 2017-02-02

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 39

Registration Number: NCT01894581

Locations: 🇺🇸
University of Colorado Denver Anschutz Medical Campus, Aurora, Colorado, United States

A Cost-effectiveness Study of Nicotine Patches Distributed Through a Quitline

Not Applicable

Completed

Conditions: Smoking Cessation

Interventions: Drug: Nicotine Patch

First Posted Date: 2013-06-28

Last Posted Date: 2016-02-11

Lead Sponsor: University of Colorado, Denver

Target Recruit Count: 1495

Registration Number: NCT01889771

Adequacy of Perioperative Cefazolin for Surgery Antibiotic Prophylaxis in Obese Patients

Phase 4

Withdrawn

Conditions: Obesity

Interventions: Drug: Standard Dose Group
Drug: Weight Based Group

First Posted Date: 2013-06-26

Last Posted Date: 2017-12-06

Lead Sponsor: University of Colorado, Denver

Registration Number: NCT01886742

Locations: 🇺🇸
University of Colorado Hospital, Aurora, Colorado, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy